|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_on1202481001 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
201031s2020 si o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e rda
|e pn
|c EBLCP
|d YDX
|d N$T
|d OCLCO
|d N$T
|d OCLCF
|d YDX
|d OCLCO
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1198713468
|a 1202448652
|
020 |
|
|
|a 9789811468216
|q (electronic book)
|
020 |
|
|
|a 9811468214
|q (electronic book)
|
029 |
1 |
|
|a AU@
|b 000070392551
|
035 |
|
|
|a (OCoLC)1202481001
|z (OCoLC)1198713468
|z (OCoLC)1202448652
|
050 |
|
4 |
|a RC667
|b .K86 2020
|
082 |
0 |
4 |
|a 616.1/061
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Kumar, A. Bharath.
|
245 |
1 |
0 |
|a Pharmacotherapeutic Management of Cardiovascular Disease Complications :
|b a textbook for medical students.
|
264 |
|
1 |
|a Singapore :
|b Bentham Science Publishers,
|c [2020]
|
300 |
|
|
|a 1 online resource (361 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- Introduction to Heart Anatomy and Physiology -- INTRODUCTION -- Location of Heart -- Size and Shape of the Heart -- Chambers and Blood Circulation in the Heart -- Heart Chambers -- Blood Vessels -- Heart valves -- ANATOMY OF HEART -- Left Side of the Heart -- Right Side of the Heart -- Covering Layers of Heart -- The Internal Structural Pattern of the Heart -- Right Atrium -- Left Atrium -- Right Ventricle -- Left ventricle
|
505 |
8 |
|
|a PHYSIOLOGY OF THE HEART -- Diastole -- Conduction System of the Heart -- Cardiac Cycle -- Relaxation Phase -- Blood Supply to Heart -- Heart Sounds -- Cardiac Output -- CONCLUSION -- REFERENCES -- Role of Biomarkers in Detection of Cardiovascular Diseases -- INTRODUCTION -- IDEAL CHARACTERISTICS OF BIOMARKERS -- MYOCARDIUM INJURY RISK PREDICTION BIOMARKERS -- Cardiac Troponin -- High-Sensitivity Cardiac Troponin (hs-cTn) -- Heart-Type Fatty Acid Binding Protein (H-FABP) -- INFLAMMATION PREDICTION BIOMARKERS -- High-Sensitivity C-reactive Protein (hs-CRP)
|
505 |
8 |
|
|a Growth-Differentiation Factor-15 (GDF-15) -- Fibrinogen -- Uric Acid -- PLAQUES RUPTURE ASSESSMENT BIOMARKERS -- Myeloperoxidase (MPO) -- Matrix Metalloproteinases -- Pregnancy-Associated Plasma Protein-A (PAPP-A) -- Platelet Activation Biomarkers -- Secretory Phospholipase A2 (sPLA2) -- Lipoprotein-Associated Phospholipase A2 -- Soluble CD40 Ligand (sCD40L) -- BIOMARKERS OF NEUROHORMONAL ACTIVATION -- Mid-Regional-Pro-Adrenomedullin -- MYOCARDIAL DYSFUNCTION DETECTION BIOMARKERS ST -- Endothelin-1 (ET-1) -- Galectin-3 -- Neuregulin-1 -- BIOMARKERS OF MICRO RNAS (MIRNAS)
|
505 |
8 |
|
|a OTHER BIOMARKERS INVOLVED IN THE PREDICTION OF CARDIOVASCULAR DISEASE RISK PREDICTION -- Neutrophil Gelatinase-Associated Lipocalin -- Natriuretic Peptides -- Apelin -- Growth Differentiation Factor-15 -- Cyclophilin A -- Prolactin -- Heart-type Fatty Acid Binding Protein (H-FABP) -- CONCLUSION -- REFERENCES -- Diagnostic Investigations for Detection of Cardiovascular Diseases -- INTRODUCTION -- CARDIOVASCULAR DISEASES: A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS -- Coronary Heart Disease -- Cerebrovascular Disease -- Peripheral Arterial Disease -- Rheumatic Heart Disease
|
505 |
8 |
|
|a Congenital Heart Disease -- Deep Vein Thrombosis and Pulmonary Embolism -- RISK FACTORS FOR CARDIOVASCULAR DISEASE -- DIAGNOSTIC INVESTIGATIONS FOR CARDIOVASCULAR DISEASES -- Blood Analysis -- Biomarkers for Detection of Cardiovascular Disease -- B-type Natriuretic Peptides -- Blood Urea Nitrogen -- C-reactive Protein -- Enzymes -- Fibrinogen -- Blood Sugar Test -- Homocysteine -- Lipid -- OTHER CARDIOVASCULAR DISEASE DIAGNOSTIC INVEST-IGATIONS -- CT Scan -- Cardiac Catheterization -- Echocardiography -- Ejection Fraction Testing -- Electrocardiogram -- Electrophysiology Study
|
500 |
|
|
|a Cardiac Stress Test.
|
520 |
|
|
|a Pharmacotherapeutic Management of Cardiovascular Disease Complications is an essential textbook which comprehensively informs the reader about a broad variety of cardiovascular pathologies and their management through drug therapy. Key Features:- Features 22 chapters, with 17 chapters dedicated to the management of a wide range of cardiomyopathies and related complications- Introduces readers to heart anatomy and physiology, for both medical and pharmacology students- Covers information on cardiovascular disease biomarkers as well as current and new technologies for diagnostic procedures- Prov.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Cardiovascular system
|x Diseases
|x Chemotherapy.
|
650 |
|
6 |
|a Appareil cardiovasculaire
|x Maladies
|x Chimiothérapie.
|
650 |
|
7 |
|a Cardiovascular system
|x Diseases
|x Chemotherapy
|2 fast
|
700 |
1 |
|
|a Umashankar, M. S.
|
776 |
0 |
8 |
|i Print version:
|a Umashankar, M.S.
|t Pharmacotherapeutic Management of Cardiovascular Disease Complications: a Textbook for Medical Students.
|d Singapore : Bentham Science Publishers, ©2020
|z 9789811468193
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2636075
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6371155
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 2636075
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 301580035
|
994 |
|
|
|a 92
|b IZTAP
|